What should I know about helicobacter pylori?

Helicobacter pylori is a spiral-shaped bacterium that colonizes the stomach lining. It is very common worldwide, with prevalence varying by region and socioeconomic factors. Most infected individuals are asymptomatic, but it is a major cause of chronic gastritis, peptic ulcer disease, and is classified as a Group 1 carcinogen for gastric cancer. Diagnosis is typically via stool antigen test, urea breath test, or endoscopy with biopsy. Treatment involves combination antibiotic therapy (e.g., triple or quadruple therapy) with a proton pump inhibitor. Antibiotic resistance is a growing concern, so susceptibility testing may be considered. Eradication is recommended for those with active ulcers, MALT lymphoma, or at high risk for gastric cancer. However, routine testing and treatment of asymptomatic individuals is controversial and not universally recommended. The 'hygiene hypothesis' suggests that H. pylori may have protective effects against some conditions like GERD and asthma, but this is not a reason to avoid treatment when indicated. Evidence is strong for its role in ulcer disease and cancer, but weaker for benefits of eradication in asymptomatic populations. Consumers should not self-treat; medical guidance is essential.